Author

Frank Gary Renshaw

Observed names: F G Renshaw, F. G. Renshaw, F. Gary Renshaw, F.G. Renshaw

Institution: Vertex Pharmaceuticals (United States)

Observed institutions: Bayer (United States), University of Pittsburgh, Dana-Farber Cancer Institute, Royal Marsden Hospital, Rocky Mountain Cancer Centers, Janssen Research & Development (United States), Vertex Pharmaceuticals (United States)

OpenAlex ID: A5013402754

A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens

2007 · for the ET-743-INT-11 study group, C N Krasner, et al. · British Journal of Cancer · 104

A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

2008 · M. von Mehren, R.J. Schilder, et al. · Annals of Oncology · 50

A phase 1b trial of PI3K inhibitor copanlisib (BAY 80-6946) combined with the allosteric-MEK inhibitor refametinib (BAY 86-9766) in patients with advanced cancer.

2014 · Ramesh K. Ramanathan, Daniel D. Von Hoff, et al. · Journal of Clinical Oncology · 16

Sensitivity to halichondrin analog E7389 and hemiasterlin analog E7974 correlates with βIII tubulin isotype expression in human breast cancer cell lines

2005 · S. Agoulnik, G. Kuznetsov, et al. · Journal of Clinical Oncology · 14

Abstract CT012: Phase 1 trial of first-in-class ATR inhibitor VX-970 in combination with cisplatin (Cis) in patients (pts) with advanced solid tumors (NCT02157792)

2016 · Geoffrey Shapiro, Robert Wesolowski, et al. · Cancer Research · 12

Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients.

2014 · Richard D. Kim, Steven R. Alberts, et al. · Journal of Clinical Oncology · 6

427 Identification of response marker genes of the antitumor sulfonamide indisulam (E7070)

2004 · T. Owa, Y. Ozawa, et al. · European Journal of Cancer Supplements · 4

A phase II multicenter study of the cell cycle inhibitor indisulam in refractory metastatic breast carcinoma

2005 · R. Oratz, J. Blum, et al. · Journal of Clinical Oncology · 3

A phase I study of E7070, a chloroindolyl-sulfonamide, in combination with irinotecan in gastrointestinal and thoracic carcinomas

2005 · D. P. Ryan, J. P. Eder, et al. · Journal of Clinical Oncology · 2

Dilutional Anemia

2002 · Anthony J. Bowdler, Frank Gary Renshaw · Humana Press eBooks · 1

Splenic Pooling and Survival of Blood Cells

2002 · Anthony J. Bowdler, Frank Gary Renshaw · Humana Press eBooks

Works count: 11

Citation count: 212

H-index: 6

I10-index: 5